Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia

Background: Helicobacter pylori antimicrobial resistance rates differ among countries and even between different areas of a country. In Colombia, the most commonly used antimicrobials for the treatment of H pylori infection are amoxicillin, clarithromycin and metronidazole. Aim: To determine antimic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Álvarez,Adalucy, Moncayo,José Ignacio, Santacruz,Jorge Javier, Corredor,Luisa Fernanda, Reinosa,Elizabeth, Martínez,José William, Beltrán,Leonardo
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2009
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009001000005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872009001000005
record_format dspace
spelling oai:scielo:S0034-988720090010000052009-12-02Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en ColombiaÁlvarez,AdalucyMoncayo,José IgnacioSantacruz,Jorge JavierCorredor,Luisa FernandaReinosa,ElizabethMartínez,José WilliamBeltrán,Leonardo Antibacterial agents Helicobacter pylori Metronidazole Background: Helicobacter pylori antimicrobial resistance rates differ among countries and even between different areas of a country. In Colombia, the most commonly used antimicrobials for the treatment of H pylori infection are amoxicillin, clarithromycin and metronidazole. Aim: To determine antimicrobial susceptibility of H pylori strains isolated in Colombia. Materials and methods: Eighty eight strains of H pylori were isolated and identified by microbiological methods and confirmed with polymerase chain reaction (PCR). The detection of antimicrobial resistance to amoxicillin, clarithromycin, metronidazole and tetraclycline, was conducted by the Etest method. Mutations in the 23S rDNA, involved in resistance to clarithromycin, were detected using PCR and restriction fragment lenght polymorphism. Results: Eighty eight and 2.2% of the strains were resistant to metronidazole and clarithromycin, respectively. No isolate was simultaneously resistant to amoxicillin or tetracycline. The two clarithromycin resistant strains were homozygous for the A2143G mutation. No mutations were found in the remaining 86 susceptible strains. Conclusions: The high rate of metronidazole resistance in our population precludes the use of this drug for the empirical treatment of Hpylori infection.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.137 n.10 20092009-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009001000005es10.4067/S0034-98872009001000005
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Antibacterial agents
Helicobacter pylori
Metronidazole
spellingShingle Antibacterial agents
Helicobacter pylori
Metronidazole
Álvarez,Adalucy
Moncayo,José Ignacio
Santacruz,Jorge Javier
Corredor,Luisa Fernanda
Reinosa,Elizabeth
Martínez,José William
Beltrán,Leonardo
Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia
description Background: Helicobacter pylori antimicrobial resistance rates differ among countries and even between different areas of a country. In Colombia, the most commonly used antimicrobials for the treatment of H pylori infection are amoxicillin, clarithromycin and metronidazole. Aim: To determine antimicrobial susceptibility of H pylori strains isolated in Colombia. Materials and methods: Eighty eight strains of H pylori were isolated and identified by microbiological methods and confirmed with polymerase chain reaction (PCR). The detection of antimicrobial resistance to amoxicillin, clarithromycin, metronidazole and tetraclycline, was conducted by the Etest method. Mutations in the 23S rDNA, involved in resistance to clarithromycin, were detected using PCR and restriction fragment lenght polymorphism. Results: Eighty eight and 2.2% of the strains were resistant to metronidazole and clarithromycin, respectively. No isolate was simultaneously resistant to amoxicillin or tetracycline. The two clarithromycin resistant strains were homozygous for the A2143G mutation. No mutations were found in the remaining 86 susceptible strains. Conclusions: The high rate of metronidazole resistance in our population precludes the use of this drug for the empirical treatment of Hpylori infection.
author Álvarez,Adalucy
Moncayo,José Ignacio
Santacruz,Jorge Javier
Corredor,Luisa Fernanda
Reinosa,Elizabeth
Martínez,José William
Beltrán,Leonardo
author_facet Álvarez,Adalucy
Moncayo,José Ignacio
Santacruz,Jorge Javier
Corredor,Luisa Fernanda
Reinosa,Elizabeth
Martínez,José William
Beltrán,Leonardo
author_sort Álvarez,Adalucy
title Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia
title_short Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia
title_full Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia
title_fullStr Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia
title_full_unstemmed Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia
title_sort resistencia a metronidazol y claritromicina en aislamientos de helicobacter pylori de pacientes dispépticos en colombia
publisher Sociedad Médica de Santiago
publishDate 2009
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009001000005
work_keys_str_mv AT alvarezadalucy resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia
AT moncayojoseignacio resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia
AT santacruzjorgejavier resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia
AT corredorluisafernanda resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia
AT reinosaelizabeth resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia
AT martinezjosewilliam resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia
AT beltranleonardo resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia
_version_ 1718436468124286976